Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort

1. Sánchez-Bayona, R.
2. Lopez de Sa, A.
3. Jerez Gilarranz, Y.
4. Sanchez de Torre, A.
5. Alva, M.
6. Echavarria, I.
7. Moreno, F.
8. Tolosa, P.
9. Herrero Lopez, B.
10. de Luna, A.
11. Lema, L.
12. Gamez Casado, S.
13. Madariaga, A.
14. López-Tarruella, S.
15. Manso, L.
16. Bueno-Muiño, C.
17. Garcia-Saenz, J.A.
18. Ciruelos, E.
19. Martin, M.